Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.22.2.2
Condensed Consolidated Balance Sheets - USD ($)
Sep. 30, 2022
Dec. 31, 2021
Current assets:    
Cash $ 12,469,607 $ 17,267,978
Accounts receivable, net 689,094 349,836
Inventory 1,138,290 1,019,696
Unbilled revenue 120,359 100,422
VAT receivable 355,118 491,417
Prepaid expenses – current portion 67,341 97,068
Equity method investment 5,056
Other current assets 48,539
Total current assets 14,844,865 19,374,956
Property and equipment, net 1,186,099 1,042,859
Right of use asset 865,115 22,643
Intangible assets, net 56,250 75,000
Prepaid expenses – long term portion 42,424 49,867
Equity method investment 3,540,508
Total assets 20,535,261 20,565,325
Current liabilities:    
Accounts payable and accrued liabilities 1,087,044 1,063,344
Contract liabilities 35,009 36,765
Note payable coronavirus loans– current portion 55,750 56,391
Due to related party 15,692 35,308
Lease liabilities - current 145,284 19,763
Provision for income taxes 15,468 56,781
Stock subscription payable 1,400,000
Liabilities from discontinued operations 112,397 112,397
Total current liabilities 1,466,644 2,780,749
Long term liabilities:    
Note payable coronavirus loans– long term 157,958 253,757
Lease liabilities - long term 718,010
Total Liabilities 2,342,612 3,034,506
Stockholders’ Equity:    
Preferred Stock, $0.0001 par value; 3,333,333 shares authorized
Common stock, $0.0001 par value; 50,000,000 shares authorized, 9,649,096 shares issued and outstanding as of September 30, 2022 and 7,053,146 outstanding at December 31, 2021 965 705
Additional paid-in capital 48,481,636 39,513,093
Accumulated (deficit) (30,205,435) (21,986,215)
Accumulated other comprehensive income (loss) (84,517) 3,236
Total stockholders’ equity 18,192,649 17,530,819
Total liabilities and stockholders’ equity $ 20,535,261 $ 20,565,325